etomoxir has been researched along with u 0126 in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (u 0126) | Trials (u 0126) | Recent Studies (post-2010) (u 0126) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 2,816 | 2 | 1,213 |
| Protein | Taxonomy | etomoxir (IC50) | u 0126 (IC50) |
|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.29 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.25 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.07 | |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.2816 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.2529 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, MW; Baek, SH; Dan, JM; Kim, JE; Kim, JY; Kim, YW; Lee, IK; Park, SY | 1 |
1 other study(ies) available for etomoxir and u 0126
| Article | Year |
|---|---|
AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antioxidants; Apoptosis; Butadienes; Caprylates; Cell Differentiation; Cell Line; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Fumonisins; Humans; Multienzyme Complexes; Nitriles; Osteoblasts; Palmitates; Protein Serine-Threonine Kinases; Ribonucleotides; Time Factors | 2008 |